Pleiotropy of cancer susceptibility variants on the risk of non-Hodgkin lymphoma: the PAGE consortium.
<h4>Background</h4>Risk of non-Hodgkin lymphoma (NHL) is higher among individuals with a family history or a prior diagnosis of other cancers. Genome-wide association studies (GWAS) have suggested that some genetic susceptibility variants are associated with multiple complex traits (plei...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0089791&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850162107535851520 |
|---|---|
| author | Unhee Lim Jonathan M Kocarnik William S Bush Tara C Matise Christian Caberto Sungshim Lani Park Christopher S Carlson Ewa Deelman David Duggan Megan Fesinmeyer Christopher A Haiman Brian E Henderson Lucia A Hindorff Laurence N Kolonel Ulrike Peters Daniel O Stram Maarit Tiirikainen Lynne R Wilkens Chunyuan Wu Charles Kooperberg Loïc Le Marchand |
| author_facet | Unhee Lim Jonathan M Kocarnik William S Bush Tara C Matise Christian Caberto Sungshim Lani Park Christopher S Carlson Ewa Deelman David Duggan Megan Fesinmeyer Christopher A Haiman Brian E Henderson Lucia A Hindorff Laurence N Kolonel Ulrike Peters Daniel O Stram Maarit Tiirikainen Lynne R Wilkens Chunyuan Wu Charles Kooperberg Loïc Le Marchand |
| author_sort | Unhee Lim |
| collection | DOAJ |
| description | <h4>Background</h4>Risk of non-Hodgkin lymphoma (NHL) is higher among individuals with a family history or a prior diagnosis of other cancers. Genome-wide association studies (GWAS) have suggested that some genetic susceptibility variants are associated with multiple complex traits (pleiotropy).<h4>Objective</h4>We investigated whether common risk variants identified in cancer GWAS may also increase the risk of developing NHL as the first primary cancer.<h4>Methods</h4>As part of the Population Architecture using Genomics and Epidemiology (PAGE) consortium, 113 cancer risk variants were analyzed in 1,441 NHL cases and 24,183 controls from three studies (BioVU, Multiethnic Cohort Study, Women's Health Initiative) for their association with the risk of overall NHL and common subtypes [diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL), chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL)] using an additive genetic model adjusted for age, sex and ethnicity. Study-specific results for each variant were meta-analyzed across studies.<h4>Results</h4>The analysis of NHL subtype-specific GWAS SNPs and overall NHL suggested a shared genetic susceptibility between FL and DLBCL, particularly involving variants in the major histocompatibility complex region (rs6457327 in 6p21.33: FL OR=1.29, p=0.013; DLBCL OR=1.23, p=0.013; NHL OR=1.22, p=5.9 × E-05). In the pleiotropy analysis, six risk variants for other cancers were associated with NHL risk, including variants for lung (rs401681 in TERT: OR per C allele=0.89, p=3.7 × E-03; rs4975616 in TERT: OR per A allele=0.90, p=0.01; rs3131379 in MSH5: OR per T allele=1.16, p=0.03), prostate (rs7679673 in TET2: OR per C allele=0.89, p=5.7 × E-03; rs10993994 in MSMB: OR per T allele=1.09, p=0.04), and breast (rs3817198 in LSP1: OR per C allele=1.12, p=0.01) cancers, but none of these associations remained significant after multiple test correction.<h4>Conclusion</h4>This study does not support strong pleiotropic effects of non-NHL cancer risk variants in NHL etiology; however, larger studies are warranted. |
| format | Article |
| id | doaj-art-53e5c007be0f4ae58066a720fecbce12 |
| institution | OA Journals |
| issn | 1932-6203 |
| language | English |
| publishDate | 2014-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-53e5c007be0f4ae58066a720fecbce122025-08-20T02:22:39ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0193e8979110.1371/journal.pone.0089791Pleiotropy of cancer susceptibility variants on the risk of non-Hodgkin lymphoma: the PAGE consortium.Unhee LimJonathan M KocarnikWilliam S BushTara C MatiseChristian CabertoSungshim Lani ParkChristopher S CarlsonEwa DeelmanDavid DugganMegan FesinmeyerChristopher A HaimanBrian E HendersonLucia A HindorffLaurence N KolonelUlrike PetersDaniel O StramMaarit TiirikainenLynne R WilkensChunyuan WuCharles KooperbergLoïc Le Marchand<h4>Background</h4>Risk of non-Hodgkin lymphoma (NHL) is higher among individuals with a family history or a prior diagnosis of other cancers. Genome-wide association studies (GWAS) have suggested that some genetic susceptibility variants are associated with multiple complex traits (pleiotropy).<h4>Objective</h4>We investigated whether common risk variants identified in cancer GWAS may also increase the risk of developing NHL as the first primary cancer.<h4>Methods</h4>As part of the Population Architecture using Genomics and Epidemiology (PAGE) consortium, 113 cancer risk variants were analyzed in 1,441 NHL cases and 24,183 controls from three studies (BioVU, Multiethnic Cohort Study, Women's Health Initiative) for their association with the risk of overall NHL and common subtypes [diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL), chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL)] using an additive genetic model adjusted for age, sex and ethnicity. Study-specific results for each variant were meta-analyzed across studies.<h4>Results</h4>The analysis of NHL subtype-specific GWAS SNPs and overall NHL suggested a shared genetic susceptibility between FL and DLBCL, particularly involving variants in the major histocompatibility complex region (rs6457327 in 6p21.33: FL OR=1.29, p=0.013; DLBCL OR=1.23, p=0.013; NHL OR=1.22, p=5.9 × E-05). In the pleiotropy analysis, six risk variants for other cancers were associated with NHL risk, including variants for lung (rs401681 in TERT: OR per C allele=0.89, p=3.7 × E-03; rs4975616 in TERT: OR per A allele=0.90, p=0.01; rs3131379 in MSH5: OR per T allele=1.16, p=0.03), prostate (rs7679673 in TET2: OR per C allele=0.89, p=5.7 × E-03; rs10993994 in MSMB: OR per T allele=1.09, p=0.04), and breast (rs3817198 in LSP1: OR per C allele=1.12, p=0.01) cancers, but none of these associations remained significant after multiple test correction.<h4>Conclusion</h4>This study does not support strong pleiotropic effects of non-NHL cancer risk variants in NHL etiology; however, larger studies are warranted.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0089791&type=printable |
| spellingShingle | Unhee Lim Jonathan M Kocarnik William S Bush Tara C Matise Christian Caberto Sungshim Lani Park Christopher S Carlson Ewa Deelman David Duggan Megan Fesinmeyer Christopher A Haiman Brian E Henderson Lucia A Hindorff Laurence N Kolonel Ulrike Peters Daniel O Stram Maarit Tiirikainen Lynne R Wilkens Chunyuan Wu Charles Kooperberg Loïc Le Marchand Pleiotropy of cancer susceptibility variants on the risk of non-Hodgkin lymphoma: the PAGE consortium. PLoS ONE |
| title | Pleiotropy of cancer susceptibility variants on the risk of non-Hodgkin lymphoma: the PAGE consortium. |
| title_full | Pleiotropy of cancer susceptibility variants on the risk of non-Hodgkin lymphoma: the PAGE consortium. |
| title_fullStr | Pleiotropy of cancer susceptibility variants on the risk of non-Hodgkin lymphoma: the PAGE consortium. |
| title_full_unstemmed | Pleiotropy of cancer susceptibility variants on the risk of non-Hodgkin lymphoma: the PAGE consortium. |
| title_short | Pleiotropy of cancer susceptibility variants on the risk of non-Hodgkin lymphoma: the PAGE consortium. |
| title_sort | pleiotropy of cancer susceptibility variants on the risk of non hodgkin lymphoma the page consortium |
| url | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0089791&type=printable |
| work_keys_str_mv | AT unheelim pleiotropyofcancersusceptibilityvariantsontheriskofnonhodgkinlymphomathepageconsortium AT jonathanmkocarnik pleiotropyofcancersusceptibilityvariantsontheriskofnonhodgkinlymphomathepageconsortium AT williamsbush pleiotropyofcancersusceptibilityvariantsontheriskofnonhodgkinlymphomathepageconsortium AT taracmatise pleiotropyofcancersusceptibilityvariantsontheriskofnonhodgkinlymphomathepageconsortium AT christiancaberto pleiotropyofcancersusceptibilityvariantsontheriskofnonhodgkinlymphomathepageconsortium AT sungshimlanipark pleiotropyofcancersusceptibilityvariantsontheriskofnonhodgkinlymphomathepageconsortium AT christopherscarlson pleiotropyofcancersusceptibilityvariantsontheriskofnonhodgkinlymphomathepageconsortium AT ewadeelman pleiotropyofcancersusceptibilityvariantsontheriskofnonhodgkinlymphomathepageconsortium AT davidduggan pleiotropyofcancersusceptibilityvariantsontheriskofnonhodgkinlymphomathepageconsortium AT meganfesinmeyer pleiotropyofcancersusceptibilityvariantsontheriskofnonhodgkinlymphomathepageconsortium AT christopherahaiman pleiotropyofcancersusceptibilityvariantsontheriskofnonhodgkinlymphomathepageconsortium AT brianehenderson pleiotropyofcancersusceptibilityvariantsontheriskofnonhodgkinlymphomathepageconsortium AT luciaahindorff pleiotropyofcancersusceptibilityvariantsontheriskofnonhodgkinlymphomathepageconsortium AT laurencenkolonel pleiotropyofcancersusceptibilityvariantsontheriskofnonhodgkinlymphomathepageconsortium AT ulrikepeters pleiotropyofcancersusceptibilityvariantsontheriskofnonhodgkinlymphomathepageconsortium AT danielostram pleiotropyofcancersusceptibilityvariantsontheriskofnonhodgkinlymphomathepageconsortium AT maarittiirikainen pleiotropyofcancersusceptibilityvariantsontheriskofnonhodgkinlymphomathepageconsortium AT lynnerwilkens pleiotropyofcancersusceptibilityvariantsontheriskofnonhodgkinlymphomathepageconsortium AT chunyuanwu pleiotropyofcancersusceptibilityvariantsontheriskofnonhodgkinlymphomathepageconsortium AT charleskooperberg pleiotropyofcancersusceptibilityvariantsontheriskofnonhodgkinlymphomathepageconsortium AT loiclemarchand pleiotropyofcancersusceptibilityvariantsontheriskofnonhodgkinlymphomathepageconsortium |